March 14, 2011
Xiao Xiao, PhD, has been named vice chair of the Division of Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy.
Xiao, the Fred Eshelman Distinguished Professor of Gene Therapy, joined the division in 2006. His research focuses on gene delivery and therapy for various genetic and acquired diseases. His research on muscular dystrophy, especially Duchenne Muscular Dystrophy, has received international recognition, and his groundbreaking work has been developed into the first gene therapy phase I clinical trial for DMD in the United States.
In addition to assisting the division chair with the operation and administration of the division, Xiao’s primary duty will be to direct and lead research and graduate education within MOPH.
“We chose Xiao for this role because he is an excellent scientist with good leadership quality,” says division chair Leaf Huang, PhD, also a Fred Eshelman Distinguished Professor. “We share a common vision of how to further build our division into an outstanding drug-delivery program.”
Before coming to UNC-Chapel Hill, Xiao was a member of the faculty in the Department of Molecular Genetics & Biochemistry and the Department of Orthopedic Surgery at the University of Pittsburgh, where he received his PhD in biology. He earned two degrees in China, an MS in biochemistry at Wuhan University and a BS in pharmaceutical chemistry from the Shanghai Medical University School of Pharmacy.
Latest News
Dean Angela Kashuba receives Carolina Alumni Faculty Service Award
RASP poster presentations capture student research
